Combined pulmonary fibrosis and emphysema;Syndrome d'emphysème des sommets et fibrose pulmonaire des bases combinés

Presse Medicale

Volumn 36, Issue 6 II, 2007, Pages 936-944

  Cottin, Vincent ^a   Brillet, Pierre Yves ^b   Nunes, Hilario ^c   Cordier, Jean François ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b Service de radiologie

^c AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; PULMONARY HYPERTENSION; RISK FACTOR; SHORT SURVEY; SMOKING;

EID: 34249680285     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.03.005     Document Type: Short Survey

References (62)

1. Wiggins J., Strickland B., and Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 84 (1990) 365-369
2. Hiwatari N., Shimura S., and Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration (Herrlisheim) 60 (1993) 354-358
3. Doherty M.J., Pearson M.G., O'Grady E.A., Pellegrini V., and Calverley P.M. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 52 (1997) 998-1002
4. Cottin V., Youakim C., Frognier R., Bayle J.Y., and Cordier J.F. Combined pulmonary fibrosis and emphysema - A severe disorder with subnormal pulmonary volumes (abstract). Am J Respir Crit Care Med. (2002) 165A139
5. Grubstein A., Bendayan D., Schactman I., Cohen M., Shitrit D., and Kramer M.R. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med 99 (2005) 948-954
6. Cottin V., Nunes H., Brillet P.Y., Delaval P., Devouassoux G., and Tillie-Leblond I. et al. and the Groupe d'Etude et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26 (2005) 586-593
7. Cottin V., and Cordier J.F. Fibrose pulmonaire idiopathique. Rev Prat 56 (2006) 1155-1171
8. Daniil Z., Koutsokera A., and Gourgoulianis K. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J 27 (2006) 434
9. Desai S.R., Veeraraghavan S., Hansell D.M., Nikolakopolou A., Goh N.S., Nicholson A.G., et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 232 (2004) 560-567
10. Dawson J.K., Fewins H.E., Desmond J., Lynch M.P., and Graham D.R. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 56 (2001) 622-627
11. Fenlon H.M., Casserly I., Sant S.M., and Breatnach E. Plain radiographs and thoracic high-resolution CT in patients with ankylosing spondylitis. AJR Am J Roentgenol 168 (1997) 1067-1072
12. American Thoracic Society/European Respiratory Society Statement. Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med 168 (2003) 818-900
13. Baumgartner K.B., Samet J.M., Stidley C.A., Colby T.V., and Waldron J.A. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155 (1997) 242-248
14. Schwartz D.A., Merchant R.K., Helmers R.A., Gilbert S.R., Dayton C.S., and Hunninghake G.W. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 144 (1991) 504-506
15. Cherniack R.M., Colby T.V., Flint A., Thurlbeck W.M., Waldron Jr. J.A., Ackerson L., et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 151 (1995) 1180-1188
16. Wells A.U., Desai S.R., Rubens M.B., Goh N.S., Cramer D., Nicholson A.G., et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 167 (2003) 962-969
17. Mura M., Zompatori M., Pacilli A.M., Fasano L., Schiavina M., and Fabbri M. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 51 (2006) 257-265
18. Fulmer J.D., Roberts W.C., von Gal E.R., and Grystal R.G. Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. J Clin Invest 60 (1977) 595-610
19. Cottin V., and Cordier J.F. Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. Am J Respir Crit Care Med 172 (2005) 1605 (author reply 1605-6)
20. Hoyle G.W., Li J., Finkelstein J.B., Eisenberg T., Liu J.Y., Lasky J.A., et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol 154 (1999) 1763-1775
21. Lundblad L.K., Thompson-Figueroa J., Leclair T., Sullivan M.J., Poynter M.E., Irvin C.G., et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 171 (2005) 1363-1370
22. Lucatelli M., Bartalesi B., Cavarra E., Fineschi S., Lunghi B., and Martorana P.A. et al. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res (2005) 683
23. Snider G.L., Lucey E.C., Faris B., Jung-Legg Y., Stone P.J., and Franzblau C. Cadmium-chloride-induced air-space enlargement with interstitial pulmonary fibrosis is not associated with destruction of lung elastin. Implications for the pathogenesis of human emphysema. Am Rev Respir Dis 137 (1988) 918-923
24. Albaugh G., Kann B., Strande L., Vemulapalli P., Hewitt C., and Alexander J.B. Nicotine induces endothelial TNF-alpha expression, which mediates growth retardation in vitro. J Surg Res 99 (2001) 381-384
25. Zoppini G., Faccini G., Muggeo M., Zenari L., Falezza G., and Targher G. Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes. J Clin Endocrinol Metab 86 (2001) 3805-3808
26. McCrea K.A., Ensor J.E., Nall K., Bleecker E.R., and Hasday J.D. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 150 (1994) 696-703
27. Li J.M., Cui T.X., Shiuchi T., Liu H.W., Min L.J., Okumura M., et al. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts. Arterioscler Thromb Vasc Biol 24 (2004) 80-84
28. Sekhon H.S., Keller J.A., Proskocil B.J., Martin E.L., and Spindel E.R. Maternal nicotine exposure upregulates collagen gene expression in fetal monkey lung. Association with alpha7 nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol 26 (2002) 31-41
29. Eddahibi S., Chaouat A., Morrell N., Fadel E., Fuhrman C., Bugnet A.S., et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 108 (2003) 1839-1844
30. Cottin V., Donsbeck A.V., Revel D., Loire R., and Cordier J.F. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158 (1998) 1286-1293
31. Cottin V., Loire R., Chalabreysse L., Thivolet F., and Cordier J.F. Pneumopathie interstitielle non spécifique: une nouvelle entité au sein des pneumopathies interstitielles diffuses idiopathiques. Rev Mal Respir 18 (2001) 25-33
32. Elliot T.L., Lynch D.A., Newell Jr. J.D., Cool C., Tuder R., Markopoulou K., et al. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr 29 (2005) 339-345
33. Vehmas T., Kivisaari L., Huuskonen M.S., and Jaakkola M.S. Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers. Eur Respir J 21 (2003) 866-871
34. Satoh K., Kobayashi T., Misao T., Hitani Y., Yamamoto Y., Nishiyama Y., et al. CT assessment of subtypes of pulmonary emphysema in smokers. Chest 120 (2001) 725-729
35. Wells A.U., King A.D., Rubens M.B., Cramer D., du Bois R.M., and Hansell D.M. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 155 (1997) 1367-1375
36. Ostrow D., and Cherniack R.M. Resistance to airflow in patients with diffuse interstitial lung disease. Am Rev Respir Dis 108 (1973) 205-210
37. Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos. Am J Respir Crit Care Med 170 (2004) 691-715
38. Barnhart S., Hudson L.D., Mason S.E., Pierson D.J., and Rosenstock L. Total lung capacity. An insensitive measure of impairment in patients with asbestosis and chronic obstructive pulmonary disease?. Chest 93 (1988) 299-302
39. Jodoin G., Gibbs G.W., Macklem P.T., McDonald J.C., and Becklake M.R. Early effects of asbestos exposure on lung function. Am Rev Respir Dis 104 (1971) 525-535
40. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 (2002) 277-304
41. King Jr. T.E., Costabel U., Cordier J.F., DoPico G.A., duBois R.M., Lynch D., et al. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 (2000) 646-664
42. Wells A.U., Hansell D.M., Rubens M.B., Cullinan P., Haslam P.L., Black C.M., et al. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 150 (1994) 462-468
43. Hansell D., and Nicholson A.G. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Sem Respir Crit Care Med. 24 (2003) 377-391
44. Cottin V., Capron F., Grenier P., and Cordier J.F. Pneumopathies interstitielles diffuses idiopathiques. Classification de Consensus International Multidisciplinaire de l'American Thoracic Society et de l'European Respiratory Society, principales entités anatomo-cliniques, et conduite du diagnostic. Rev Mal Respir 21 (2004) 299-318
45. Weitzenblum E., Ehrhart M., Rasaholinjanahary J., and Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration (Herrlisheim) 44 (1983) 118-127
46. Nadrous H.F., Pellikka P.A., Krowka M.J., Swanson K.L., Chaowalit N., Decker P.A., et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 128 (2005) 2393-2399
47. Lettieri C.J., Nathan S.D., Barnett S.D., Ahmad S., and Shorr A.F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129 (2006) 746-752
48. Kessler R., Faller M., Weitzenblum E., Chaouat A., Aykut A., Ducolone A., et al. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 164 (2001) 219-224
49. Weitzenblum E., Hirth C., Ducolone A., Mirhom R., Rasaholinjanahary J., and Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36 (1981) 752-758
50. Chaouat A., Bugnet A.S., Kadaoui N., Schott R., Enache I., Ducolone A., et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 189-194
51. Thabut G., Dauriat G., Stern J.B., Logeart D., Levy A., Marrash-Chahla R., et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127 (2005) 1531-1536
52. Laaban J.P., Diebold B., Zelinski R., Lafay M., Raffoul H., and Rochemaure J. Noninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary disease. Chest 96 (1989) 1258-1262
53. King Jr. T.E., Tooze J.A., Schwarz M.I., Brown K.R., and Cherniack R.M. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164 (2001) 1171-1181
54. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 158 (1998) 49-59
55. Seersholm N., Dirksen A., and Kok-Jensen A. Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiency. Eur Respir J 7 (1994) 1985-1987
56. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353 (2005) 2229-2242
57. Raghu G., Brown K.K., Bradford W.Z., Starko K., Noble P.W., Schwartz D.A., et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350 (2004) 125-133
58. Wang Z., Zheng T., Zhu Z., Homer R.J., Riese R.J., Chapman Jr. H.A., et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192 (2000) 1587-1599
59. Ghofrani H.A., Wiedemann R., Rose F., Schermuly R.T., Olschewski H., Weissmann N., et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360 (2002) 895-900
60. Madden B.P., Allenby M., Loke T.K., and Sheth A. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease. Vascul Pharmacol 44 (2006) 372-376
61. Olschewski H., Ghofrani H.A., Walmrath D., Schermuly R., Temmesfeld-Wollbruck B., Grimminger F., et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 160 (1999) 600-607
62. Schroll S., Sebah D., Artz M., Wensel R., Stoelcker B., Resch J., et al. Improvement of bleomycin induced pulmonary hypertension and pulmonary fibrosis by the endothelin antagonist bosentan. Proc Am Thoracic Soc. (2006) 3A420 (abstract)